Solubility and Buffer Selection in Peptide Work

Solubility problems are among the most common practical frustrations in peptide research, and they are largely predictable from sequence composition.

Charge determines behaviour

A peptide’s net charge at a given pH is the dominant driver of aqueous solubility. Summing the acidic residues — aspartate and glutamate — against the basic residues — lysine, arginine, and histidine — gives an approximate isoelectric point, the pH at which net charge is zero. Solubility is generally at a minimum near that point, because molecules with no net charge lack the electrostatic repulsion that keeps them apart. Moving pH away from the isoelectric point in either direction typically improves dissolution.

Hydrophobicity and aggregation

Sequences rich in hydrophobic residues, or with a strong propensity to form beta-sheet structure, resist aqueous dissolution and tend to aggregate. These sequences often require an initial dissolution in a small volume of a stronger solvent before dilution into aqueous buffer, rather than direct addition of water.

Choosing conditions

General practice is to begin with the mildest conditions likely to work and escalate only as needed. Basic peptides frequently dissolve in slightly acidic aqueous conditions; acidic peptides in slightly basic ones. Sonication and gentle warming can assist, though both should be applied cautiously to sequences containing oxidation-prone residues.

Compatibility with the assay

A solvent that dissolves the peptide is only useful if it is compatible with the experiment. Organic co-solvents carry their own biological effects at higher concentrations, so the final concentration in the assay should be recorded and, where possible, matched in vehicle controls. A dissolution strategy that solves a physical problem while introducing an experimental artefact has not solved anything.

Disclosure. This article is educational and summarises published scientific literature. It is not medical advice, and it does not describe outcomes you should expect. These statements have not been evaluated by the Food and Drug Administration, and the products discussed are not intended to diagnose, treat, cure, or prevent any disease. The products discussed are supplied for laboratory and research use only and are not for human or veterinary use, administration, or consumption. For adults 21 and over.